Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir (Near-Rwanda)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Rwanda Biomedical Center
Gilead Sciences
Information provided by (Responsible Party):
Philip Grant, Stanford University
ClinicalTrials.gov Identifier:
NCT02104700
First received: April 1, 2014
Last updated: July 15, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)